StonvexLoading…
StonvexStonvexStonvexCore line items from CLBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $470.95M | $451.43M | $394.98M | $309.67M |
Operating Income | $67.99M | $-15.91M | $46.05M | $116.88M |
Net Income | $51.77M | $-11.65M | $36.09M | $86.17M |
EPS (Diluted) | $0.51 | $-0.11 | $0.35 | $0.81 |
Total Assets | $11.02B | $10.48B | $10.65B | $10.41B |
Total Liabilities | $9.86B | $9.40B | $9.61B | $9.35B |
Cash & Equivalents | $340.81M | $289.22M | $423.25M | $179.23M |
Free Cash Flow OCF − CapEx | $58.56M | $25.88M | $33.08M | $134.95M |
Shares Outstanding | 103.98M | 104.76M | 104.92M | 108.97M |